189 related articles for article (PubMed ID: 30953306)
1. Incentives Versus Defaults: Cost-Effectiveness of Behavioral Approaches for HIV Screening.
Wagner Z; Montoy JCC; Drabo EF; Dow WH
AIDS Behav; 2020 Feb; 24(2):379-386. PubMed ID: 30953306
[TBL] [Abstract][Full Text] [Related]
2. Cash incentives versus defaults for HIV testing: A randomized clinical trial.
Montoy JCC; Dow WH; Kaplan BC
PLoS One; 2018; 13(7):e0199833. PubMed ID: 29979742
[TBL] [Abstract][Full Text] [Related]
3. How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings.
Farnham PG; Sansom SL; Hutchinson AB
Med Decis Making; 2012; 32(3):459-69. PubMed ID: 22247422
[TBL] [Abstract][Full Text] [Related]
4. Programmatic cost evaluation of nontargeted opt-out rapid HIV screening in the emergency department.
Haukoos JS; Campbell JD; Conroy AA; Hopkins E; Bucossi MM; Sasson C; Al-Tayyib AA; Thrun MW;
PLoS One; 2013; 8(12):e81565. PubMed ID: 24391706
[TBL] [Abstract][Full Text] [Related]
5. Financial Incentives to Increase Uptake of Pediatric HIV Testing (FIT): study protocol for a randomised controlled trial in Kenya.
Wagner AD; Njuguna IN; Neary J; Omondi VO; Otieno VA; Babigumira J; Maleche-Obimbo E; Wamalwa DC; John-Stewart GC; Slyker JA
BMJ Open; 2018 Oct; 8(10):e024310. PubMed ID: 30287676
[TBL] [Abstract][Full Text] [Related]
6. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.
Holtgrave DR
PLoS Med; 2007 Jun; 4(6):e194. PubMed ID: 17564488
[TBL] [Abstract][Full Text] [Related]
7. Behavioral economics-based incentives supported by mobile technology on HIV knowledge and testing frequency among Latino/a men who have sex with men and transgender women: Protocol for a randomized pilot study to test intervention feasibility and acceptability.
Linnemayr S; MacCarthy S; Kim A; Giguere R; Carballo-Dieguez A; Barreras JL
Trials; 2018 Oct; 19(1):540. PubMed ID: 30290851
[TBL] [Abstract][Full Text] [Related]
8. Comparing Cost-Effectiveness of HIV Testing Strategies: Targeted and Routine Testing in Washington, DC.
Castel AD; Choi S; Dor A; Skillicorn J; Peterson J; Rocha N; Kharfen M
PLoS One; 2015; 10(10):e0139605. PubMed ID: 26465771
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive theoretical framework for the implementation and evaluation of opt-out HIV testing.
Leidel S; Leslie G; Boldy D; Girdler S
J Eval Clin Pract; 2017 Apr; 23(2):301-307. PubMed ID: 27451938
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis.
Baggaley RF; Irvine MA; Leber W; Cambiano V; Figueroa J; McMullen H; Anderson J; Santos AC; Terris-Prestholt F; Miners A; Hollingsworth TD; Griffiths CJ
Lancet HIV; 2017 Oct; 4(10):e465-e474. PubMed ID: 28768604
[TBL] [Abstract][Full Text] [Related]
11. The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study.
Adamson B; El-Sadr W; Dimitrov D; Gamble T; Beauchamp G; Carlson JJ; Garrison L; Donnell D
Value Health; 2019 Feb; 22(2):194-202. PubMed ID: 30711064
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of novel nonmonetary incentives to promote HIV testing.
Chamie G; Schaffer EM; Ndyabakira A; Emperador DM; Kwarisiima D; Camlin CS; Havlir DV; Kahn JG; Kamya MR; Thirumurthy H
AIDS; 2018 Jul; 32(11):1443-1451. PubMed ID: 29683850
[TBL] [Abstract][Full Text] [Related]
13. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
[TBL] [Abstract][Full Text] [Related]
14. Benefits of HIV screening of blood transfusions in Zambia.
Foster S; Buvé A
Lancet; 1995 Jul; 346(8969):225-7. PubMed ID: 7616804
[TBL] [Abstract][Full Text] [Related]
15. The role of behavioral economic incentive design and demographic characteristics in financial incentive-based approaches to changing health behaviors: a meta-analysis.
Haff N; Patel MS; Lim R; Zhu J; Troxel AB; Asch DA; Volpp KG
Am J Health Promot; 2015; 29(5):314-23. PubMed ID: 25928816
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility of HIV Testing Programs Among Men Who Have Sex with Men in the United States.
Zulliger R; Maulsby C; Solomon L; Baytop C; Orr A; Nasrullah M; Shouse L; DiNenno E; Holtgrave D
AIDS Behav; 2017 Mar; 21(3):619-625. PubMed ID: 27624729
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of opt-out inpatient HIV screening at an urban teaching hospital.
Osorio G; Hoenigl M; Quartarolo J; Barger K; Morris SR; Reed SL; Lee J; Little SJ
AIDS Care; 2017 Aug; 29(8):1014-1018. PubMed ID: 28114789
[TBL] [Abstract][Full Text] [Related]
19. Novel emergency department registration kiosk for HIV screening is cost-effective.
Hsieh YH; Holtgrave DR; Peterson S; Gaydos CA; Rothman RE
AIDS Care; 2016; 28(4):483-6. PubMed ID: 26477440
[TBL] [Abstract][Full Text] [Related]
20. Costs and effectiveness of finding new HIV diagnoses by using rapid testing in transgender communities.
Shrestha RK; Sansom SL; Schulden JD; Song B; Smith LC; Ramirez R; Mares-DelGrasso A; Heffelfinger JD
AIDS Educ Prev; 2011 Jun; 23(3 Suppl):49-57. PubMed ID: 21689036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
